Blog

Roche CMV Test for Hematopoietic Stem Cell Transplants Gets FDA OK – GenomeWeb

Roche CMV Test for Hematopoietic Stem Cell Transplants Gets FDA OK
GenomeWeb
NEW YORK (GenomeWeb) – Roche today announced that that the US Food and Drug Administration has approved the firm's cytomegalovirus (CMV) test for use with hematopoietic stem cell transplant recipients. The real-time PCR-based Cobas …
Roche : FDA-approved CMV Test On Hematopoietic Stem Cell Transplant RecipientsNasdaq



all 2 news articles »

2016-05-25 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.